Table 1.
Strains and plasmids used in this study.
| Strains or plasmids | Relevant characteristics | References |
|---|---|---|
| STRAINS | ||
| C. glabrata ATCC 2001 | Wild-type strain | Roetzer et al., 2008 |
| C. glabrata ATCC 55 | his3Δtrp1Δura3Δ mutant strain | Roetzer et al., 2008 |
| Cgasg1Δ | C. glabrata ATCC 55 (asg1Δ::CgURA3) | This study |
| Cgasg1Δ/CgASG1 | Cgasg1Δ (pY13-CgASG1) | This study |
| Cgasg1Δ/CgASG1-GFP | Cgasg1Δ (pY13-CgASG1-GFP) | This study |
| Cghal9Δ | C. glabrata ATCC 55 (hal9Δ::CgURA3) | This study |
| Cghal9Δ/CgHAL9 | Cghal9Δ (pY13-CgHAL9) | This study |
| Cghal9Δ/CgHAL9-GFP | Cghal9Δ (pY13-CgHAL9-GFP) | This study |
| C. glabrata ATCC 55/GFP | C. glabrata ATCC 55 (pY13-GFP) | This study |
| Cgasg1Δhal9Δ | Cgasg1Δ (hal9Δ::CgHIS3) | This study |
| PLASMIDS | ||
| pYES2 | 2μ, Amp, URA3, PGAL | Invitrogen (California, USA) |
| pY13 | CEN6/ARSH4, Amp, HIS3, PTEF | Turbo (Beijing, China) |
| pY13-CgASG1 | CEN6/ARSH4, Amp, HIS3, PTEF-CgASG1 | This study |
| pY13-CgASG1-GFP | CEN6/ARSH4, Amp, HIS3, PTEF-CgASG1-GFP | This study |
| pY13-CgHAL9 | CEN6/ARSH4, Amp, HIS3, PTEF-CgHAL9 | This study |
| pY13-CgHAL9-GFP | CEN6/ARSH4, Amp, HIS3, PTEF-CgHAL9-GFP | This study |
| pY13-GFP | CEN6/ARSH4, Amp, HIS3, HIS3, PTEF-GFP | This study |